German science and technology company Merck KGaA plans to acquire Canadian hydrogel membrane products provider Natrix Separations.

The acquisition strengthens Merck’s mAb and vaccine manufacturing capabilities.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Healthcare services provider Genius Lead plans to acquire 11% stake in pharmaceutical product developer Rui Kang Pharmaceutical Group Investments from Chinese pharmaceutical distributor New Ray Medicine International Holding for HK$44.21m ($5.64m).

Both Genius Lead and Rui Kang are based in Hong Kong.

"Sanofi has announced the acquisition of US-based biotechnology company Protein Sciences for $750m."

Sanofi has announced the acquisition of US-based biotechnology company Protein Sciences for $750m.

The acquisition will enable the French pharmaceutical company to expand its influenza vaccine portfolio.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Chinese biotechnology company Guangdong VTR BioTech has announced the acquisition of a 15.2% stake in a biotechnology company based in Hunan for CNY38.1m ($5.74m).

The transaction increases Guangdong VTR Bio-Tech’s stake in the entity from 75% to 90.2%.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact